As informed in Stock Exchange Announcement No. 4/2008 the shareholders in general meeting in December 2007 authorised Coloplast to establish a share buy-back programme of up to DKK 1bn during 2008 and 2009. The first part of DKK 500m will be exercised in the period from 6 March 2008 to 30 September 2008. Under the programme the following transactions have been executed during the period 5.5.2008-9.5.2008 - see enclosed PDF.
Recommended Reading
-
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
Read More -
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
Read More